Skip to main content
AIMD
NASDAQ Life Sciences

Insider's Stake in Ainos, Inc. Jumps to 10.98% Following Significant RSU Grant

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
8
Price
$1.97
Mkt Cap
$14.314M
52W Low
$1.26
52W High
$4.5
Market data snapshot near publication time

summarizeSummary

Ting Chuan Lee's beneficial ownership in Ainos, Inc. increased to 10.98% after receiving a grant of 570,000 fully vested RSUs, valued at over $1.1 million.


check_boxKey Events

  • Significant RSU Grant to Insider

    Ting Chuan Lee received 570,000 fully vested Restricted Stock Units on April 15, 2026, under the Ainos, Inc. 2023 Stock Incentive Plan.

  • Beneficial Ownership Increases to 10.98%

    Following the RSU grant, Ting Chuan Lee's beneficial ownership in Ainos, Inc. now totals 935,707 shares, representing 10.98% of the common stock outstanding.

  • Substantial Equity Value

    The RSU grant is valued at approximately $1.12 million based on the current stock price of $1.97 per share.


auto_awesomeAnalysis

Ting Chuan Lee, a reporting person, significantly increased his beneficial ownership in Ainos, Inc. to 10.98% of outstanding shares after receiving a grant of 570,000 fully vested Restricted Stock Units. This substantial equity award, valued at over $1.1 million, aligns insider interests with shareholder value, especially as the company faces a "going concern" warning from its recent 10-K filing. The increase in insider ownership could signal confidence in the company's future despite its financial challenges, potentially providing a boost to investor sentiment.

At the time of this filing, AIMD was trading at $1.97 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $14.3M. The 52-week trading range was $1.26 to $4.50. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed AIMD - Latest Insights

AIMD
Apr 17, 2026, 4:20 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
AIMD
Apr 17, 2026, 4:19 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
AIMD
Apr 17, 2026, 4:19 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
AIMD
Apr 17, 2026, 4:17 PM EDT
Filing Type: 4
Importance Score:
8
AIMD
Apr 17, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
8
AIMD
Apr 17, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
8
AIMD
Apr 17, 2026, 8:00 AM EDT
Source: Access Newswire
Importance Score:
7
AIMD
Apr 01, 2026, 9:00 AM EDT
Source: Access Newswire
Importance Score:
9
AIMD
Mar 30, 2026, 5:30 PM EDT
Filing Type: 10-K
Importance Score:
9
AIMD
Mar 30, 2026, 5:30 PM EDT
Filing Type: 8-K
Importance Score:
8